GDP-fucose synthetase from Escherichia coli: structure of a unique member of the short-chain dehydrogenase/reductase family that catalyzes two distinct reactions at the same active site  by Somers, William S et al.
GDP-fucose synthetase from Escherichia coli: structure of a
unique member of the short-chain dehydrogenase/reductase
family that catalyzes two distinct reactions at the same active site
William S Somers, Mark L Stahl and Francis X Sullivan*
Background:  In all species examined, GDP-fucose is synthesized from GDP-
mannose in a three-step reaction catalyzed by two enzymes, GDP-mannose
4,6 dehydratase and a dual function 3,5-epimerase-4-reductase named GDP-
fucose synthetase. In this latter aspect fucose biosynthesis differs from that of
other deoxy and dideoxy sugars, in which the epimerase and reductase
activities are present as separate enzymes. Defects in GDP-fucose
biosynthesis have been shown to affect nodulation in bacteria, stem
development in plants, and are associated with the immune defect leukocyte
adhesion deficiency type II in humans.
Results:  We have determined the structure of GDP-fucose synthetase from
Escherichia coli at 2.2 Å resolution. The structure of GDP-fucose synthetase is
closely related to that of UDP-galactose 4-epimerase and more distantly to other
members of the short-chain dehydrogenase/reductase family. We have also
determined the structures of the binary complexes of GDP-fucose synthetase
with its substrate NADPH and its product NADP+. The nicotinamide cofactors
bind in the syn and anti conformations, respectively.
Conclusions:  GDP-fucose synthetase binds its substrate, NADPH, in the
proper orientation (syn) for transferring the 4-pro-S hydride of the nicotinamide.
We have observed a single binding site in GDP-fucose synthetase for the
second substrate, GDP-4-keto,6-deoxy-mannose. This implies that both the
epimerization and reduction reactions occur at the same site in the enzyme. As is
the case for all members of the short-chain family of dehydrogenase/reductases,
GDP-fucose synthetase retains the Ser-Tyr-Lys catalytic triad. We propose that
this catalytic triad functions in a mechanistically equivalent manner in both the
epimerization and reduction reactions. Additionally, the X-ray structure has
allowed us to identify other residues that are potentially required for substrate
binding and catalysis.
Introduction
Fucose is found widely distributed in the complex carbo-
hydrates and glycoconjugates of bacteria, plants, and
animals. In these organisms it plays diverse roles, ranging
from its involvement in nodulation in Azorhizobium [1], to
development of shoots in Arabidopsis [2], to adhesion of
leukocytes to activated endothelia in humans as part of
the selectin ligand [3]. In humans, a defect in GDP-fucose
biosynthesis is responsible for the immune disorder leuko-
cyte adhesion deficiency type II [4–6]. Fucose is added
to these glycoconjugates by specific transferases that use
GDP-fucose as the sugar donor. GDP-fucose in turn is syn-
thesized primarily from GDP-mannose in a three-step
reaction involving two enzymes, as shown in Figure 1.
The first step is the oxidation at C4 of the mannose ring
and subsequent reduction at C6. This is carried out by
a NADP+-dependent enzyme, GDP-mannose 4,6 dehy-
dratase (GMD) [7–9]. The next two steps of the reaction,
the epimerization at C3 and C5 of the mannose ring and
the subsequent NADPH-dependent reduction at C4 to
yield GDP-fucose, are carried out by a single dual-func-
tion enzyme, GDP-fucose synthetase (GFS) [9–11]. In
E. coli this enzyme is encoded by the fcl gene, previously
known as wcaG [12,13]. It is in these final two steps that
GDP-fucose biosynthesis differs from synthesis of other
deoxy sugars derived from dTDP-glucose and CDP-
glucose. In the latter pathways, separate epimerase and
reductase enzymes, encoded by independent genes,
perform the roles of the dual function epimerase/reduc-
tase of the GDP-fucose pathway (reviewed in [14]).
The human homolog of GFS has recently been identified
as the FX protein [11]. As with the E. coli enzyme, it is a
homodimer that binds NADP(H) and catalyzes both the
epimerization and reduction of GDP-4-keto, 6-deoxy-
mannose. Human GFS has 29% identity with the E. coli
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protein. More distantly related to both the human and
E. coli enzymes is UDP-galactose 4-epimerase (GalE),
which catalyzes the reversible epimerization of UDP-
glucose to UDP-galactose. A tightly bound NAD+ that is
reduced and then oxidized during the catalytic cycle is
essential to catalysis. UDP-galactose 4-epimerase is a
member of the short-chain dehydrogenase/reductase (SDR)
family (reviewed in [15]). This family of enzymes cat-
alyzes a diverse set of enzymatic reactions spanning five
EC classes using a conserved set of active-site residues,
including a Ser-Tyr-Lys catalytic triad.
Here we report the structure of E. coli GDP-fucose syn-
thetase and its complexes with substrate NADPH and
product NADP+. The structure of the protein is closely
related to that of UDP-galactose 4-epimerase and other
members of the SDR family. The nicotinamide ring of
the NADP+ adopts either the syn or anti conformation,
depending upon its oxidation state. We have identified a
single pocket capable of functioning as the binding site for
GDP-sugar substrate, implying that both the epimeriza-
tion and reduction reactions occur at this site. Given the
sequence similarity of GDP-mannose 4,6 dehydratase to
GDP-fucose synthetase and UDP-galactose 4-epimerase,
it seems likely that both the enzymes involved in GDP-
fucose biosynthesis evolved from a single protogene.
Results and discussion
GDP-fucose synthetase is a member of the SDR family
The GFS monomer forms a roughly two-domain structure
that provides the enzyme with the ability to bind cofactor
and substrate (Figure 2a). The NADP(H)-binding domain
is the larger of the two and contains a central six-stranded
β sheet flanked by two sets of parallel α helices, common
to the family of NAD(P)-binding proteins (reviewed in
[16]). The second, predominantly C-terminal domain is
smaller and is responsible for binding substrate. It extends
away from the other domain and forms a globular cluster
of three α helices and two small β sheets.
The N-terminal domain begins with an alternating α/β
repeat forming the first five strands and four flanking
helices, labeled in Figure 2a as 1–A–2–B–3–C–D–4–E–5.
Residue Asn165 marks the first transition into the second,
substrate-binding domain, where it enters a short β strand
(strand 6), a 12-residue loop, helix F, and two more strands
(strands 7 and 8). At that point the chain returns to the first
domain, forming helices G and H and the final strand of the
central β sheet, strand 9. The remaining residues of GFS
form the bulk of the substrate-binding domain and consist
of the secondary structural elements 10–I–11–12–J–K, ter-
minating with a short piece of coil.
The structure of GFS reveals it to be a member of the
SDR family of enzymes (reviewed in [15]). This family of
enzymes catalyzes diverse sets of reactions using a con-
served core tertiary protein fold and a Ser-Tyr-Lys triad of
catalytic residues. GalE belongs to the SDR family and
forms its own branch with enzymes that catalyze dehydro-
genations, dehydrations, and epimerizations and isomer-
izations. The relationship between E. coli GFS, previously
known as YefB, and GalE has been noted previously [17],
and GFS has been assigned to the GalE branch of SDRs
on the basis of sequence homology. Consistent with this
observation, the structures of GFS and GalE are closely
related. The overall sequence identity between GalE and
GFS is 25%, resulting in structures with a root mean
square (rms) difference in 184 Cα positions of only 0.8 Å
(Figure 3). Although most of the secondary structural ele-
ments of the two enzymes superimpose well, there are
also some significant differences.
The first large difference occurs after the N-terminal
strand–helix–strand in which GalE has a 22-residue inser-
tion, forming an additional flanking helix and strand at
the front of the molecule (see Figure 4 for amino acid
alignment). This insertion provides residues in GalE that
interact with the adenine ribose of NAD(H) [18] and
would cause steric clashes if NADP+ were to bind to GalE.
In the absence of this loop, Arg36 of GFS directly hydro-
gen bonds with the C2′ phosphate of NADP(H) and pro-
vides GFS with the ability to distinguish NAD(H) from
NADP(H). The absence of this loop in GFS results in
NADPH binding in a more solvent-exposed arrangement,
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Figure 1
The GDP-fucose biosynthetic pathway. The
enzymes catalyzing the steps are shown
above the arrows. GMD (GDP-mannose 4,6
dehydratase) is an NADP+-dependent enzyme
in which the NADP+ is reduced and oxidized
during the catalytic cycle. GFS, GDP-fucose
synthetase (GDP-4-keto-6 deoxy-mannose
3,5 epimerase 4-reductase). R = GDP.
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consistent with the observation that NADPH binds,
transfers the hydride and is then released as NADP+. In
contrast, GalE does not release NAD+ during the cat-
alytic cycle and the nicotinamide dinucleotide is less
solvent-exposed.
For the next 150 residues of GFS there are only minor dif-
ferences between the two proteins in the positions of
loops and flanking helices, until His170 where there is a
six-residue insertion that extends GalE further into the
solvent. Following this there is a helix in the substrate-
binding domain (helix F in GFS) that superimposes well
with GalE and then two strands (corresponding to strands
7 and 11 in GFS), shown at the top of Figure 3, that have
both moved. These strands give the substrate-binding
region of GFS a more open, solvent-exposed configuration
Research Article  Structure of GDP-fucose synthetase Somers, Stahl and Sullivan    1603
Figure 2
The tertiary and quaternary structure of GFS.
(a) Stereoview ribbon representation of a
GFS monomer showing bound NADP+ in ball-
and-stick representation. The N terminus of
the protein is indicated. The secondary
structure elements are labeled — strands with
numbers and helices with letters — proceeding
from the N terminus towards the C terminus.
(b) Ribbon representation of the GFS dimer
showing the extensive interface. The figure is
viewed down the twofold axis. One monomer
is in red, the other in blue. Interacting strands
and helices are labeled as in (a); those
belonging to the right-hand dimer are denoted
by primes. The figures were produced using
MOLSCRIPT [49] and rendered using
Raster3D [50].
and lack the ‘flap’ in GalE that interacts with the sub-
strate. As is indicated by modeling of GDP-4-keto, 6-deoxy
mannose binding to GFS (see below), some movement of
residues within these loops may occur, as has been seen
for other SDR enzymes [19]. The only remaining large
difference between the two structures is an insertion of a
helix from Ala228–Asn235 in GFS. This insertion is far
removed from the substrate- or cofactor-binding regions
and therefore has an unknown function.
Results from both dynamic light scattering and size exclu-
sion chromatography (data not shown) indicate that GFS
exists as a dimer in solution. In the crystal lattice GFS
exists as a crystallographic dimer and has an extensive
monomer–monomer interface, burying 1530 Å2 of water-
accessible surface per monomer, as calculated with the
CCP4 programs AREAIMOL and RESAREA [20]. The
core of the dimer interface is formed by a four-helix
bundle consisting of the flanking helices D and E that
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Figure 3
Stereoview Cα trace of GFS (blue)
superimposed on GalE (red). In each case the
bound cofactor is shown in ball-and-stick
representation with the same color scheme as
the protein. For GFS, every tenth Cα atom is
shown as a ball and numbered where
possible.
Figure 4
The program QUANTA was used to
superimpose E. coli UDP-galactose
4-epimerase (GalE) and E. coli GDP-fucose
synthetase (coli_GFS), as shown in Figure 3.
The two sequences were then aligned on the
basis of their structure, and the human GDP-
fucose synthetase (human_GFS) amino acid
sequence was aligned to this pair. Identical
residues are boxed in red, homologous
residues in grey, and residues identical in two
of the three proteins in blue. Residues present
in all three sequences are indicated below the
sequence alignment.
GalE         1 -MRVLVTGGSGYIGSHTCVQLLQNG-HDVIILDNLCNSKRSVLPVIERLGGKHPTFVEGD
coli_GFS     3 KQRVFIAGHRGMVGSAIRRQLEQRGDVELVLRTR----------------------DELN
human_GFS    8 -MRILVTGGSGLVGKAIQKVVADGAGLPGEDWVF-------------------VSSKDAD
consensus    1   R    G  G  G                                              
GalE        59 IRNEALMTEILHDHAIDTVIHFAGLKA-VGESVQKPLEYYDNNVNGTLRLISAMRAANVK
coli_GFS    41 LLDSRAVHDFFASERIDQVYLAAAKVGGIVANNTYPADFIYQNMMIESNIIHAAHQNDVN
human_GFS   48 LTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGAR
consensus   61                   V   A                   N                 
GalE       118 NFIFSSSATVYGDNPKIPYVES-FPTGTPQ---SPYGKSKLMVEQILTDLQKAQPDWSIA
coli_GFS   101 KLLFLGSSCIYPKLAKQPMAESELLQGTLEPTNEPYAIAKIAGIKLCESYNRQY-GRDYR
human_GFS  108 KVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQY-GCTFT
consensus  121       S          P  E     G        Y   K                    
GalE       174 LLRYFNPVGAHPSGDMGEDPQGIPNNLMPYIAQVAVGR----RDSLAIFGNDYPTEDGTG
coli_GFS   160 SVMPTNLYGPH------DNFHPSNSHVIPALLRRFHEATAQNAPDVVVWGS------GTP
human_GFS  167 AVIPTNVFGPHDNF------NIEDGHVLPGLIHKVHLAKS-SGSALTVWGT------GNP
consensus  181      N  G H                 P                    G       G  
GalE       230 VRDYIHVMDLADGHVVAMEKLANK------PGVHIYNLGAGVGNSVLDVVNAFSKACGKP
coli_GFS   208 MREFLHVDDMAAASIHVMELAHEVWLENTQPMLSHINVGTGVDCTIRELAQTIAKVVGYK
human_GFS  214 RRQFIYSLDLAQLFIWVLREYNE-------VEPIILSVGEEDEVSIKEAAEAVVEAMDFH
consensus  241  R      D A                           G                     
GalE       284 VNYHFAPRREGDLPAYWADASKADRELNWRVTRTLDEMAQDTWHWQSRHPQGYPD
coli_GFS   268 GRVVFDASKPDGTPRKLLDVTRLHQ-LGWYHEISLEAGLASTYQWFLENQDRF  
human_GFS  267 GEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQARK
consensus  301     F                     L              T  W          Structure
interact with each other via a twofold rotation. This inter-
face also has some contacts with the loop Leu125–Leu129.
The predominant interactions are between hydrophobic
sidechains on the long flanking helices, along with several
hydrogen bonds at the periphery of the interface. This
extensive interface presumably explains why the monomer
is not observed in solution. Multimerization through a
four-helix-bundle motif is a common feature in the SDR
family, with GalE [21,22], 17β-hydroxysteroid dehydroge-
nase [23], and dihydropteridine reductase [24] being typical
examples of dimers formed this way.
NADP(H) binding
We obtained binary complexes with either NADP+ or
NADPH bound to GFS. NADP+ lies against one face of
the central β sheet with the N-terminal end of the first
helix in GFS directed towards one of the adenine phos-
phoryl oxygens (Figures 2, 3, and 5a). NADP+ binds in
an extended conformation, such that it contacts almost
every β strand and positions the nicotinamide ring in
close proximity to the catalytic domain. The adenine and
nicotinamide ribose conformations are C2′ endo and C3′
endo, respectively, with the nicotinamide ring in the anti
conformation with respect to the ribose ring. The inter-
actions made with the protein are a combination of direct
and water-mediated hydrogen bonds, together with some
hydrophobic interactions. The adenine ring packs between
the sidechain of Arg36 and the sidechains of Leu41, Ala63
and Ile86. Arg36, which is disordered in the NADP+-free
structure, also makes hydrogen bonds with the ribose phos-
phoryl oxygens (Nε-OP3 and NH2-OP3, 2.5 Å and 2.4 Å,
respectively). The only hydrogen bond to the adenine
Research Article  Structure of GDP-fucose synthetase Somers, Stahl and Sullivan    1605
Figure 5
The NADP(H)-binding site. (a) Stereoview ball-
and-stick representation of the bonding of
NADP+ to GFS. The protein is shown in dark
green and the cofactor in blue. Water
molecules are shown as red balls and potential
hydrogen bonds are shown as thin black lines.
(b) A close-up stereoview of the NADP(H)-
binding region. The bound NADPH is shown in
blue and the bound NADP+ in orange.
moiety is from the N6 to the OD1 of Asn40. One other
phosphoryl oxygen also makes a water-mediated hydro-
gen bond with the N of Arg36. The remaining water-
mediated hydrogen bond is between the adenine ribose
O3 and the N of Arg12. The interactions with the phos-
phate groups are similar to the characteristic NAD(P)-
binding domains of the dehydrogenases [16]. The turn
between the end of the N-terminal strand and the N-ter-
minal helix contains the characteristic GXXGXXG motif
(single-letter amino acid code, where X is any amino
acid) also observed in the structure of GalE. The phos-
phates lie within the helix dipole at the N-terminal end
of the first helix and make hydrogen bonds with the
N atoms of Met14 (2.8 Å) and Val15 (2.8 Å). The nicoti-
namide-ribose hydroxyls make potential hydrogen bonds
with the OH of Tyr136 (2.8 Å), the Nε of Lys140 (3.0 Å)
and the carbonyl oxygen of Gly106 (2.3 Å). The nicotin-
amide ring packs against Leu166 and makes potential
hydrogen bonds with the OGs of Ser107 (2.7 Å) and
Ser108 (2.7 Å), and the N of Ser108 (3.3 Å). A compari-
son between the NADP+-free and NADP+-bound com-
plexes shows that there are surprisingly few structural
changes in GFS upon dinucleotide binding.
The alignment of E. coli and human GFS reveals that all
residues involved in NADP+ binding mentioned above
are either identical or are replaced with conservative sub-
stitutions. The exception is Arg36 of the E. coli enzyme,
which is replaced by Phe40 in the human sequence. Arg36
coordinates the 2′ phosphate group of NADP+, thereby
allowing the enzyme to discriminate between NADP+
and NAD+. The inability of phenylalanine to make the
necessary contacts that allow the enzyme to distinguish
between NADP+ and NAD+ suggests that the local struc-
tures of the two enzymes differ in this area. At this time
we cannot say which residues in the human enzyme inter-
act with the 2′ phosphate group of NADP+.
The structure of bound NADPH is superimposable on
that of NADP+, apart from the nicotinamide ring, which
rotates into the syn conformation relative to the ribose ring
(Figure 5b) and hydrogen bonds with phosphoryl oxygen.
As a consequence of this nicotinamide ring rotation, the
hydrogen bonds with residues Ser107 and Ser108 are
broken and two water molecules move into the site. One
water molecule replaces the interactions made with the
N7 and O7, and the other hydrogen bonds with Tyr136
OH and Ser107 OG.
NADPH binding in the syn confirmation allows transfer
of the pro-S hydride (B side) during catalysis. This
accords with the known stereochemistry of the hydride
transfer, (R Kumar and G-Y Xu, personal communica-
tion). Transfer of the pro-S hydride is a general feature of
SDR enzymes and NAD(P) has been shown to bind in
the syn conformation in the structures of all the SDR
enzymes solved to date [19,22,24–31]. In contrast, the
product of the GDP-fucose synthetase reaction, NADP+,
binds in the anti confirmation. It is conceivable that the
different binding mode for substrate and product may
help to account for the difference in affinity between the
two and help promote product release. However, the
gain of hydrogen bonds to the O7 and N7 of the nicotin-
amide ring in the binding of the product, NADP+, rela-
tive to the substrate, NADPH, does not support this
hypothesis. It seems more likely that the binding of
NADP+ in the anti conformation is an artifact of binding
in the absence of the GDP-sugar substrate. The model-
ing described below suggests that Ser107 and Ser108
could move to interact with the mannose ring when sub-
strate binds, and that the anti conformation seen for
NADP+ is a consequence of an empty substrate-binding
site. UDP-glucose-4-epimerase also gave complexes with
the nicotinamide ring bound in either the syn or anti
confirmation depending upon the oxidation state of the
cofactor, although, in contrast to GFS, the reduced
cofactor was bound in the anti conformation. [18,22].
However, in the structure of the ternary complex of GalE
with UDP-sugar substrates, NADH bound in the syn
conformation — the proper orientation to carry out
hydride transfer [32,33].
Substrate binding and the catalytic site
Attempts to soak the GDP-4-keto, 6-deoxy mannose
substrate or GDP into the crystals failed, so a crude
model of GDP-sugar binding was generated (Figure 6)
based on the ternary complexes of GalE [32–34]. GDP-4-
keto, 6-deoxy mannose was modeled in QUANTA and
minimized with CHARM. The resulting structure was
aligned with UDP-glucose in GalE (PDB code 1KVU),
and then moved to optimize the hydrogen bond between
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Figure 6
A ball-and-stick representation of the GDP-4-keto-6 deoxy-mannose
binding model. The proposed binding-site residues are shown with
dark bonds and the substrate/NADPH nicotinamide ring is shown with
light-grey bonds.
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the α phosphoryl oxygen and the N of Val180. Some
adjustments of torsion angles within GDP-4-keto, 6-deoxy
mannose were made to relieve some bad contacts and
maximize van der Waals interactions. This model can be
used to predict which residues may be important for sub-
strate binding and catalysis. In the model, the guanine
ring of the GDP-sugar substrate lies in a hydrophobic
pocket made by the sidechains of Leu184, Val201, and
Val180, and lies next to Trp202. In GalE this tryptophan
is replaced by a phenylalanine that partially covers the
bound substrate. When GDP-4-keto, 6-deoxy mannose
binds to GFS, this tryptophan may also move to partially
bury the substrate. The N of Val180 hydrogen bonds to a
guanosine phosphoryl oxygen that lies at the N-terminal
end of helix Val180–Ala193. The model predicts that
Lys283 and Arg209 may be involved in phosphate
binding and that Ser107, Ser108, Cys109 and Asn165
make interactions with the 4-keto sugar. The sidechain
of His179 is in a suitable position to act as the general
acid or base during catalysis. The model also places the
ketone oxygen within 4 Å of the nicotinaimde ring, in
the proper orientation for hydride transfer. The con-
served catalytic triad, residues Ser107, Tyr136, and
Lys140, occupy similar positions as in the GalE structure
and are positioned to play a role in catalysis (see below).
Mechanisms of the reactions
A common theme in the reactions catalyzed by the GalE
and other SDR enzymes is the role played by the
conserved Ser-Tyr-Lys catalytic triad. In the proposed
mechanism, the pKa of the catalytic tyrosine is lowered
via interactions with the positively charged lysine, the
ribose hydroxyls of the nicotinamide, and, potentially,
the catalytic serine [19,22,23,26,27,34]. This allows the
tyrosine to play the role of a general acid or base, depend-
ing upon the reaction being catalyzed. The catalytic serine
may also interact with the substrate, stabilizing its confor-
mation. This mechanism is supported by the structure of
ternary complexes of GalE with NADH and UDP-sugars
[18,22,32,33] and mutagensis experiments with GalE
[34,35], as well as by the structure of ternary complexes of
other SDR enzymes [19,26,27] and mutagenesis studies of
other SDR family members [36–40]. In GFS, Ser107,
Tyr136, and Lys140 are properly positioned to play an
analogous role in the epimerization and reduction reac-
tions that the enzyme catalyzes. In the GFS structure we
find the distance between Nξ of Lys140 and the hydroxyl
of Tyr136 (4.1 Å) is too great to stabilize the negative
charge on the tyrosine hydroxyl by hydrogen-bond inter-
action. Instead, as has been proposed for other SDR
enzymes, Lys140 helps to stabilize the nicotinamide sub-
strate in an active conformation via interactions with the
ribose hydroxyls and may help lower the pKa of Tyr136 by
electrostatic effects [19,26,27,34].
In contrast to GalE and other SDR enzymes, GDP-fucose
synthetase catalyzes two distinct sets of reactions, the
epimerizations of C3 and C5 of the 4-keto, 6-deoxy
mannose ring and the NADPH-dependent reduction at
C4. The epimerizations at C3 and C5 differ from the
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Figure 7
The potential mechanism of (a) the reduction
and (b) the epimerization reactions catalyzed
by GDP-fucose synthetase. R is GDP. Tyr136
plays the central role in donating a proton
during reduction and stabilizing the negatively
charged enediol during epimerization. This
facilitates both reactions at a single active
site. Ser107 assists along with interactions
from Lys140 and the nicotinamide ribose (not
shown). Alternatively Ser107 may function as
part of a proton shuttle with Tyr136, as
proposed for GalE [34]. The pro-R and pro-S
hydrogens of the nicotinamide are labelled HR
and HS, respectively.
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epimerization reaction catalyzed by GalE in that they do
not involve the transient reduction and oxidation of an
NAD+ or NADP+ cofactor. The epimerizations catalyzed
by GFS probably proceed via an enediol/enolate interme-
diate, as first proposed by Ginsberg [41]. The same mech-
anism has been proposed for the epimerization reactions
in the synthesis of related deoxy and dideoxy sugar
nucleotides (reviewed in [14,42]).
In the epimerization catalyzed by GFS we propose that
Tyr136, by virtue of its lowered pKa, plays the role of a
general acid during catalysis. It transiently protonates the
C4 oxygen, thereby stabilizing the enediol/enolate inter-
mediate. The sidechain of His179, as noted above, could
fulfil the role of a general base in one of the reactions,
abstracting a proton from C3 or C5 of the intermediate,
followed by reprotonation from the opposite face of the
sugar ring. Deprotonation of the C4 oxygen by Tyr136
acting as a general base completes the epimerization reac-
tion. As there is no structure available for the ternary
complex, we cannot identify the other residues that func-
tion as active-site acids or bases. This mechanism is con-
sistent with the observed loss of the C3 proton during
GFS-catalyzed epimerization [10] and with the ability of
GFS to catalyze the epimerization reactions in the
absence of NADPH and subsequent reduction at C4
(FXS, unpublished results).
The other reaction catalyzed by GFS, the NADPH-
dependent reduction at C4 of the 4-keto, 6-deoxy mannose
ring, is more typical of reactions catalyzed by SDR
enzymes. Here we propose that Tyr136 acts as a general
acid and protonates the C4 oxygen in concert with hydride
transfer to C4 from NADPH. Ser107 may play a role in
this reaction by acting as a proton shuttle or in stabilizing
the conformation of the substrate in the active site, both of
which have been suggested for other SDR enzymes
[19,26,27,34]. The common roles suggested for Tyr136 in
the epimerization and reduction reactions are outlined in
Figure 7. It provides the mechanistic continuity between
the distinct epimerization and reduction reactions and
suggests how they may be facilitated at the single active
site in GFS. The details of both the epimerization and
reduction reactions should be clarified by identification of
a new crystal form of GFS that binds both the NADP(H)
and GDP-sugar substrates and by site-directed mutagene-
sis of the implicated residues.
The residues in the substrate-binding site are almost
completely conserved between the human and E. coli
sequences (Figure 4). The exception is Ser108, which is
replaced with a conservative threonine mutation. Given
the sequence similarity of the residues in the active sites
of the human and E. coli enzymes, the E. coli structure
may be a reasonable starting point for identifying possible
inhibitors of human GDP-fucose synthetase.
Both enzymes involved in GDP-fucose biosynthesis
evolved from a common precursor
Comparison of amino acid sequences reveals that the first
enzyme in GDP-fucose biosynthesis, GDP-mannose 4,6
dehydratase, is as closely related to GDP-fucose syn-
thetase (24% identity) as it is to UDP-glucose 4-epimerase
(24% identity). GDP-mannose 4,6 dehydratase also con-
tains the conserved Ser-Tyr-Lys catalytic triad. This sug-
gests that all three enzymes have closely related structures
and that both the enzymes involved in GDP-fucose
biosynthesis evolved from a single ancestral gene. Addi-
tionally, it is interesting to note that the NADP+ in GMD
is transiently reduced and then reoxidized in the course of
the reaction cycle, a role analogous to the one played by
NAD+ in GalE. Both enzymes are known to bind their
cofactors tightly during the catalytic cycle in order to
prevent release of the transiently reduced nicotinamide
[43]. Comparison of their sequences reveals that the loop
that is thought to be responsible for the tight binding of
cofactor in GalE, residues Leu33–Phe54 (Figure 4), is
present in GMD (data not shown), but absent in GFS. We
predict that these residues also form a flap in GMD to
provide additional interactions for keeping the NADP+
tightly bound during the catalytic cycle.
Biological implications
Fucose is found in the glycoconjugates of bacteria,
plants and animals where it has roles in maintaining
structural integrity, as well as in molecular recogni-
tion. Defects in GDP-fucose biosynthesis have been
shown to affect nodulation in bacteria, stem develop-
ment in plants and immune regulation in humans.
GDP-fucose is synthesized from GDP-mannose by
two enzymes: an NADP+-dependent dehydratase and
a dual-function NADPH-dependent epimerase/reduc-
tase, GDP-fucose synthetase. In this latter aspect
biosynthesis of fucose differs from that of other deoxy
sugars that are the product of separate epimerase and
reductase enzymes.
Here, we report the structures of Escherichia coli
GDP-fucose synthetase and binary complexes with
NADP+ and NADPH. These structures have allowed
us to identify interactions involved in binding the
NADPH substrate and to suggest the location of the
binding site for the GDP-sugar substrate. On the basis
of these structures, it appears that the enzyme con-
tains a single active site that catalyzes both the epimer-
ization and NADPH-dependent reduction reactions.
The residues in the active sites of the human and
E. coli GDP-fucose synthetases are highly conserved.
Thus the present structure of the E. coli enzyme could
serve as a starting point for the design of inhibitors of
the human enzyme, which ultimately could lead to the
design of immunosuppressants that act by blocking
selectin-mediated cell adhesion.
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Materials and methods
Protein purification and crystallization
GFS protein was purified from an E. coli strain overexpressing the
E. coli fcl gene, essentially as described by Sullivan et al. [9]. An addi-
tional step was added to the purification. The protein pool from the
heparin Toyapearl step was made 1 M in (NH4)2SO4 and loaded onto a
Polypropyl A column (PolyLC). The column was eluted with a gradient
from 1 to 0 M (NH4)2SO4. The resulting protein was found to be
monodisperse by light-scattering analysis (DynaPro-801) and to have a
molecular weight consistent with a dimer. Similar results were obtained
by gel-filtration chromatography on a G3000 column (TosoHass). Crys-
tals measuring 0.5 × 0.5 × 0.5 mm were obtained within one week
using the vapor-diffusion hanging-drop method. Hanging drops were
set up by adding 10 µl of a 6 mg/ml protein solution in 10 mM Tris,
pH 7.4, 50 mM sodium chloride to 10 µl of the well solution consisting
of 4.0 M sodium formate.
Data collection and processing
Diffraction data were collected using an Raxis II detector mounted on
an RU200 X-ray generator running at 50 KV (100 mA), with the
MSC/Yale focusing mirrors. All data collections were performed at
18°C with exposure times between 8 and 12 minutes per one-degree
oscillation. The data were reduced with the programs DENZO and
SCALEPACK [44], giving unit cell parameters of a = 104.2 Å and
c = 74.9 Å and symmetry P3221 or P3121. The data are summarized in
Table 1. The CCP4 suite of programs [20] were used for all further
data processing leading up to heavy-atom refinement.
MIRAS phasing
Initial attempts to solve the structure using molecular replacement
with the homologous GalE structure as a search model failed. A
similar attempt at molecular replacement by Tonetti et al. using data
from similar crystals of GFS also was unsuccessful [45]. The struc-
ture was determined using three heavy-atom derivatives. Crystals
were soaked for 48 h in three different heavy-metal salts: 5 mM gold
potassium cyanide, 2 mM mercury acetate and 5 mM cadmium chlo-
ride, all dissolved in a 4.2 M sodium formate crystal-stabilization solu-
tion. The primary mercury acetate heavy-atom position was determined
by inspection of the Patterson function Harker sections and refined
using the program MLPHARE [20]. One heavy-atom site for the gold
derivative and two sites for the cadmium were located with difference
Fouriers. The space group was found to be P3221, giving maps with
good solvent protein boundaries and densities that corresponded to
many of the secondary structural elements of GalE. The gold and
mercury heavy-atom derivatives had single well-occupied heavy-atom
sites close to Cys249 in the final model, giving maps that were inter-
pretable despite many mainchain breaks. An additional heavy-metal-
binding site was seen in the cadmium derivative. Heavy-atom
refinement in SHARP [46] revealed several minor sites for each deriv-
ative and a final figure of merit of 0.75 and 0.81 for acentric and
centric reflections, respectively. After density modification in SOLOMON
[47] using a solvent content of 60%, the final figure of merit for all
reflections was 0.93. These maps were very high quality with no
mainchain breaks for the entire molecule (Figure 8a).
Model building and refinement
The model was built into the experimental maps using QUANTA (Mol-
ecular Simulations Inc.). Large pieces of GalE were used to assist with
the model building by changing the sidechain identities and moving
residues and secondary structural elements. The resulting model had
no breaks in the backbone and was refined using X-PLOR positional,
torsion-angle dynamics, and B-factor refinement, giving a final model
with the statistics shown in Table 2. The final model consists of
residues Lys3–Phe319, with the first and last two residues not visible
in the electron-density maps. The sidechains of Arg36, Asp37, Arg55
and His174 are also disordered and were modeled as alanines in the
final structure. The sidechains of Arg36 and Asp37 became well
ordered upon binding NADP+ or NADPH and were therefore included
in those complex models.
Obtaining NADP- and NADPH-bound complexes
The complex of GFS with NADP+ was obtained by placing the crystals
into 4.2 M sodium formate, 1mM NADP+ for 20 h. The resulting
complex was found to be isomorphous with cell parameters a = 104.2 Å
and c = 75.1 Å. After rigid-body refinement of the protein model in
X-PLOR [48], clear density was identified for the bound ligand in both
2Fo–Fc and Fo–Fc electron-density maps. A model of the complex was
built using the program QUANTA and sidechains were adjusted to fit
the new electron density. Refinement of the complex was performed
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Table 1
Data collection and phasing statistics.
Crystal Native KAu(CN)2 Hg(Ac)2 CdCl2 NADP NADPH
Number of crystals 2 2 1 1 1 1
Resolution range (Å) 14.0–2.2 14.0–3.0 14.0–2.8 14.0–2.8 14.0–2.3 14.0–2.2
Unique reflections 23,163 7938 11,794 11,771 20,596 24,049
Redundancy 9.1 6.2 6.9 7.2 7.9 6.9
Completeness (%) 95.9 82.6 100.0 100.0 97.4 99.6
Average I/σ 33.1 23.8 31.7 30.6 31.0 26.4
Rmerge (%)* 5.2 7.5 5.2 5.3 6.2 5.6
High-resolution shell (Å) 2.28-2.2 3.11-3.0 2.9-2.8 2.9-2.8 2.38-2.3 2.28-2.3
Shell completeness 75.8 86.3 100.0 100.0 81.0 96.7 
Shell I/σ 4.5 13.0 17.3 15.0 9.1 4.4
Riso (%)† 8.1 9.2 7.1
Heavy-atom sites 4 4 6
Phasing power (centric/acentric)‡ 2.16/2.54 2.81/3.7 2.18/2.54
Rcullis (centric/acentric)§ 0.63/0.65 0.47/0.45 0.61/0.64
*Rmerge = Σh [(Σj | Ij – <Ij> | ) / Σj <Ij>], where Ij is the intensity of a
reflection j and <Ij> is the average intensity of the reflection j.
†Riso = Σ | |FPH| – |FP| | / Σ |FP|, where FP and FPH are the native and
derivative structure-factor amplitudes, respectively. ‡Phasing
power = the root mean square ( |FH| / E ), where FH is the calculated
structure-factor amplitude from the heavy atoms and E is the lack of
closure error. §Rcullis = the lack of closure/isomorphous difference.
using positional and B-factor refinement in X-PLOR, giving a final
model with the statistics in Table 2.
The isomorphous complex with NADPH was produced by soaking
existing crystals. A 3 mM stock of NADPH was made in the 4.2 M
sodium-formate solution and fully reduced by the addition of 100 mM
sodium borohydride. After 10 h the crystal was placed into the resulting
solution, soaked for 20 h and then diffraction data were collected using
the methods described above. The crystal had cell parameters
a = 104.3 Å and c = 74.9 Å and also gave clear electron density for
NADPH in the resulting maps. This complex was refined using similar
methods to the NADP+-bound form.
Accession numbers
The coordinates of the apo-enzyme structure, the NADP+ complex, and
NADPH complex have been deposited in the Brookhaven Protein Data
Bank with accession codes 1GFS, 1FXS, and 1BSV.
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Figure 8
Electron-density maps of GFS with and
without bound cofactors. (a) Typical MIRAS
electron density after modification with
SOLOMON, contoured at 1.5σ. Part of the
final refined GFS model is shown for
reference. (b) 2Fo–Fc electron density for
NADP phased with the rigid-body refined,
uncomplexed GFS model. The final refined
model for NADP+ is shown for reference.
(c) 2Fo–Fc density for NADPH phased with
the rigid-body refined, uncomplexed GFS
model, showing a slight puckering of the
nicotinamide ring. The final refined NADPH
coordinates are shown for reference.
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